Finance

Lists
524606:BOM
Beryl Drugs Ltd
₹24,79
-0,92%
(-0,23) 1D
15 Okt., 14:37:20 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524606...
Open
₹23,08
High
₹24,97
Low
₹23,08
Mkt. cap
125,73 m
Avg. vol.
2,50 k
Volume
3,56 k
P/E ratio
19,72
52-wk high
₹27,60
52-wk low
₹15,92
EPS
₹1,26
Open
₹23,08
High
₹24,97
Low
₹23,08
Mkt. cap
125,73 m
Avg. vol.
2,50 k
Volume
3,56 k
P/E ratio
19,72
52-wk high
₹27,60
52-wk low
₹15,92
EPS
₹1,26
News stories
From web sources and news partners
About Beryl Drugs Ltd
CEO-
Employees-
Founded1993
Headquarters-
SectorPharmaceutical industry
Websiteberyldrugs.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
51,20 m
37,77 m
51,29 m
72,97 m
Cost of goods sold
25,81 m
20,37 m
34,99 m
44,30 m
Cost of revenue
25,81 m
20,37 m
34,99 m
44,30 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,77 m
7,89 m
6,52 m
6,31 m
Operating expense
21,98 m
22,56 m
7,12 m
25,35 m
Total operating expenses
47,80 m
42,93 m
42,11 m
69,65 m
Operating income
3,40 m
-5,16 m
9,18 m
3,32 m
Other non operating income
-
-
-173,00 k
-
EBT including unusual items
2,60 m
-6,08 m
8,66 m
2,70 m
EBT excluding unusual items
2,60 m
-6,08 m
8,66 m
2,70 m
Income tax expense
2,51 m
-4,40 m
3,03 m
490,00 k
Effective tax rate
96,58%
72,41%
35,03%
18,16%
Other operating expenses
12,30 m
11,49 m
-5,63 m
15,88 m
Net income
89,00 k
-1,68 m
5,62 m
2,21 m
Net profit margin
0,17%
-4,44%
10,97%
3,03%
Earnings per share
-
-
-
-
Interest and investment income
-
-
199,00 k
-
Interest expense
-802,00 k
-917,00 k
-551,00 k
-620,00 k
Net interest expenses
-802,00 k
-917,00 k
-352,00 k
-620,00 k
Depreciation and amortization charges
3,92 m
3,18 m
4,03 m
3,16 m
EBITDA
7,27 m
-2,05 m
12,89 m
7,05 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme